Wolters Kluwer new integration tool

A new service from Wolters Kluwer Health integrates several of the marketing research firm's data points into a single source, offering financial analysts and brand managers a new forecasting capability. 
The product, inThought, was developed in order to streamline forecasting capabilities for drugmakers, to help them understand where developmental drugs, medical devices and therapies are positioned in the market, and what sort of splash they could make in the future.

"With research headcounts down, there's a fundamental shift in the way analysts and pharma customers want their research delivered," said Ben Weintraub, director of research, in a statement. "Rather than simply striving to offer more data faster, our approach sifts through the clutter to synthesize what is truly important."

Clients can use the tool for monitoring global drug developments, and tap into forecasts of approval models for over 300 drugs in development.

You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.